Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jun 30, 2024 | Option Exercise | $0.73 | 8,684 | 6,348 | 265,923 | Jul 02, 2024, 06:07 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | May 28, 2024 | Option Exercise | $0.00100 | 84,000 | 84 | 250,131 | May 30, 2024, 06:10 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Mar 31, 2024 | Option Exercise | $0.68 | 7,172 | 4,884 | 166,131 | Apr 02, 2024, 08:33 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Dec 31, 2023 | Option Exercise | $0.34 | 8,469 | 2,881 | 144,432 | Jan 03, 2024, 07:36 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jan 01, 2024 | Option Exercise | $0.34 | 2,327 | 792 | 148,829 | Jan 03, 2024, 07:36 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Sep 30, 2023 | Option Exercise | $0.62 | 7,172 | 4,446 | 128,427 | Oct 03, 2023, 07:37 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jun 30, 2023 | Option Exercise | $0.86 | 10,269 | 8,780 | 111,125 | Jul 03, 2023, 06:45 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Mar 31, 2023 | Option Exercise | $1.39 | 4,286 | 5,958 | 86,355 | Apr 04, 2023, 05:17 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jan 01, 2023 | Option Exercise | $2.37 | 2,327 | 5,515 | 76,730 | Jan 03, 2023, 03:59 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Dec 31, 2022 | Option Exercise | $2.37 | 4,814 | 11,409 | 72,334 | Jan 03, 2023, 03:59 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $1.52 | 4,077 | 6,197 | 63,236 | Oct 03, 2022, 07:55 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jun 30, 2022 | Option Exercise | $2.30 | 6,999 | 16,091 | 53,402 | Jul 01, 2022, 04:07 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Mar 31, 2022 | Option Exercise | $2.55 | 1,155 | 2,945 | 36,519 | Apr 01, 2022, 05:28 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jan 01, 2022 | Option Exercise | $3.21 | 2,327 | 7,470 | 33,733 | Jan 04, 2022, 02:17 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Dec 31, 2021 | Option Exercise | $3.21 | 1,364 | 4,378 | 29,336 | Jan 04, 2022, 02:07 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Sep 30, 2021 | Option Exercise | $4.87 | 1,155 | 5,625 | 26,759 | Oct 01, 2021, 07:24 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jun 30, 2021 | Option Exercise | $5.89 | 2,310 | 13,606 | 23,973 | Jul 02, 2021, 05:10 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Feb 11, 2021 | Sale | $14.64 | 125,000 | 1,830,620 | 249,200 | Feb 16, 2021, 07:35 PM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Jan 01, 2021 | Option Exercise | $6.12 | 2,327 | 14,241 | 18,400 | Jan 05, 2021, 12:00 AM | |
MNPR | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Dec 18, 2019 | Buy | $8.00 | 125,000 | 1,000,000 | 291,667 | Dec 20, 2019, 06:33 PM |